Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
White Paper: Evidence Requirements for the Creation of IVD Reimbursement (NABM) Codes in France
Get insights from MTRC White Papers to advance your understanding on HAS assessments and evidence generation strategy for IVD tests in France
Recent news and posts
New version of the NABM nomenclature released in France
The NABM Nomenclature serves as the primary and permanent reimbursement catalog for in-vitro diagnostic tests covered under statutory health insurance in France.
On June 18, 2025, a new version of the Nomenclature of Medical Biology Procedures (NABM 98) was released. Seven new codes were introduced, including two codes under Chapter 7 "Immunology" and five codes under Chapter 19 "Medical microbiology by pathology".
Some examples are provided below:
- Chapter 7 "Immunology", subchapter 4 "Bacterial serology: Code 1356 "Syphilis: Screening test – Treponemal Test (TT) (STI without prescription)" (coefficient B-20)";
- Chapter 19 "Medical microbiology by pathology". Codes 5500 "Hepatitis B (HBV): Screening and/or diagnosis (STI without prescription)" (coefficient B-100) and 5501 "Hepatitis B (HBV): Screening and/or diagnosis – anti-HBc IgM (STI without prescription)" (coefficient B-60).
The B value is €0.25 for metropolitan France.
See the details in French here (NABM) and here (Order on NABM v.98 changes)
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.